Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Indraprastha Medical Corporation Limited
INDRAMEDCOIndraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India. Address: Sarita Vihar, New Delhi, India, 110076
Analytics
Zielpreis von Wall Street
4 137.23 INRKGV
28.9882Dividendenrendite
1.09 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen INDRAMEDCO
Dividenden-Analyse INDRAMEDCO
Dividendenwachstum über 5 Jahre
100 %Kontinuierliches Wachstum
3 JahreAusschüttungsquote 5-Jahres-Durchschnitt
41 %Verlauf der Dividende INDRAMEDCO
Bewertung der Aktie INDRAMEDCO
Finanzen INDRAMEDCO
Ergebnisse | 2019 | Dynamik |